Glenmark Pharmaceuticals on Friday mentioned its US-based unit has acquired approval from the US well being regulator to market Metronidazole Vaginal gel, within the American market. The drug agency has acquired last approval by the United States Food & Drug Administration (USFDA) for its product which is a generic model of Bausch Health US LLC’s MetroGel-Vaginal, the drug agency mentioned in a press release. According to IQVIA gross sales information for the 12-month interval ending November 2021, the MetroGel-Vaginal Gel achieved annual gross sales of roughly round USD 60.4 million. Glenmark’s present portfolio consists of 173 merchandise authorised for distribution within the US market and 46 ANDA’s pending approval with the USFDA. In addition to those inner filings, the drug agency continues to establish and discover exterior improvement partnerships to complement and speed up the expansion of its current pipeline and portfolio, Glenmark famous.Follow and join with us on Twitter, Facebook, Linkedin, Youtube
https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-generic-drug/89175539
Glenmark gets USFDA nod for generic drug, Health News, ET HealthWorld
